AR051288A1 - Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica - Google Patents
Derivados de pirazol condensado, su preparacion y su aplicacion terapeuticaInfo
- Publication number
- AR051288A1 AR051288A1 ARP050103775A ARP050103775A AR051288A1 AR 051288 A1 AR051288 A1 AR 051288A1 AR P050103775 A ARP050103775 A AR P050103775A AR P050103775 A ARP050103775 A AR P050103775A AR 051288 A1 AR051288 A1 AR 051288A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- radical
- alkoxy
- unsubstituted
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 5
- -1 alkylene radical Chemical class 0.000 abstract 5
- 125000005843 halogen group Chemical group 0.000 abstract 5
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003254 radicals Chemical class 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 150000003217 pyrazoles Chemical class 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente se refiere a derivados de pirazol condensado, procedimientos de preparacion y aplicacion en terapéutica. Reivindicacion 1: Compuesto que responde a la formula (1) en la que: A representa un radical alquileno C3-5 lineal no sustituido o sustituido una o varias veces por un alquilo C1-3; un radical -CH2-CH2-O-CH2-; W representa un enlace directo o un radical -CH2-; R1 representa un átomo de H o un alquilo C1-3; R2 representa un alquilo C1-10 no sustituido o sustituido una o varias veces por un átomo de halogeno; un grupo -B-R4; R3 representa un fenilo sustituido por uno o varios sustituyentes elegidos independientemente entre un átomo de halogeno, un alquilo C1-4, un alcoxi C1-4, un radical trifluorometilo, un radical trifluorometoxi, un naftilo no sustituido o sustituido por uno o varios sustituyentes elegidos independientemente entre un átomo de halogeno, un alquilo C1-4, un alcoxi C1-4, un radical trifluorometilo; un quinolilo no sustituido o sustituido por uno o varios sustituyentes elegidos independientemente entre un átomo de halogeno, un alquilo C1-4, un alcoxi C1-4, un radical trifluorometilo; B representa un enlace directo o u radical alquileno C1-2 no sustituido o sustituido una o varias veces por un alquilo C1-3; R4 representa un fenilo no sustituido o sustituido por uno o varios sustituyentes elegidos independientemente entre un átomo de halogeno, un alquilo C1-4, un alcoxi C1-4, un radical trifluorometilo; un radical carbocíclico no aromático C3-12, no sustituido o sustituido una o varias veces por un alquilo C1-4 o un alcoxi C1-4; un 1,2,3,4-tetrahidronaftalen-1-ilo, en el estado de base, así como en el estado de hidrato o de solvato.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0409712A FR2875230A1 (fr) | 2004-09-13 | 2004-09-13 | Derives de pyrazole condense, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051288A1 true AR051288A1 (es) | 2007-01-03 |
Family
ID=34954413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103775A AR051288A1 (es) | 2004-09-13 | 2005-09-09 | Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR051288A1 (es) |
| FR (1) | FR2875230A1 (es) |
| PE (1) | PE20060627A1 (es) |
| TW (1) | TW200621786A (es) |
| UY (1) | UY29112A1 (es) |
| WO (1) | WO2006030124A1 (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7923465B2 (en) | 2005-06-02 | 2011-04-12 | Glenmark Pharmaceuticals S.A. | Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| AU2006253842A1 (en) * | 2005-06-02 | 2006-12-07 | Glenmark Pharmaceuticals S.A. | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| WO2007001939A1 (en) * | 2005-06-27 | 2007-01-04 | Janssen Pharmaceutica N.V. | Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities |
| US8378096B2 (en) | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| US8378117B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| AU2006292051B2 (en) * | 2005-09-23 | 2012-11-15 | Janssen Pharmaceutica, N.V. | Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
| AU2006295130A1 (en) * | 2005-09-23 | 2007-04-05 | Janssen Pharmaceutica, N.V. | Tetrahydro-indazolyl cannabinoid modulators |
| DK1931335T3 (da) | 2005-09-23 | 2010-06-07 | Janssen Pharmaceutica Nv | Hexahydro-cyclooctyl-pyrazol-cannabinoid-modulatorer |
| US7825151B2 (en) | 2005-09-23 | 2010-11-02 | Janssen Pharmaceutica Nv | Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
| JP2009508953A (ja) * | 2005-09-23 | 2009-03-05 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヘキサヒドロ−シクロヘプタピラゾール系カンナビノイドモジュレーター |
| WO2007095513A1 (en) * | 2006-02-14 | 2007-08-23 | Janssen Pharmaceutica, Nv | Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators |
| US20070254911A1 (en) * | 2006-03-27 | 2007-11-01 | Mingde Xia | Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators |
| EP2139326A4 (en) * | 2007-03-21 | 2011-06-15 | Janssen Pharmaceutica Nv | METHOD OF TREATING PAIN INDUCED BY A CB2 RECEPTOR |
| AU2008229265A1 (en) * | 2007-03-21 | 2008-09-25 | Janssen Pharmaceutica N.V. | Method for treating CB2 receptor mediated pain |
| EP2269990A4 (en) * | 2008-03-25 | 2012-04-18 | Takeda Pharmaceutical | Heterocyclic compound |
| WO2010088050A2 (en) * | 2009-01-28 | 2010-08-05 | Cara Therapeutics, Inc. | Bicyclic pyrazolo-heterocycles |
| CN102596913B (zh) * | 2009-08-28 | 2016-11-09 | 艾尼纳制药公司 | 大麻素受体调节剂 |
| DK3252057T3 (da) | 2009-12-04 | 2024-06-17 | Sunovion Pharmaceuticals Inc | Multicykliske forbindelser og fremgangsmåder til anvendelse deraf |
| ES2929977T3 (es) | 2011-02-25 | 2022-12-05 | Arena Pharm Inc | Moduladores del receptor cannabinoide |
| WO2012116277A1 (en) | 2011-02-25 | 2012-08-30 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| WO2012116278A1 (en) * | 2011-02-25 | 2012-08-30 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| BR112013021549B1 (pt) | 2011-02-25 | 2022-01-11 | Arena Pharmaceuticals, Inc | Processos para preparação de forma cristalina anidra, para preparação de composição farmacêutica e para preparação de forma de dosagem, forma cristalina não solvatada anidra, composição farmacêutica, forma de dosagem, uso da referida forma cristalina e solvato |
| EP2847180B1 (en) * | 2012-05-11 | 2017-01-04 | Bayer Pharma Aktiengesellschaft | Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer |
| US20190016680A1 (en) | 2016-01-14 | 2019-01-17 | Beth Israel Deaconess Medical Center, Inc. | Mast-cell modulators and uses thereof |
| CN116283877A (zh) | 2016-07-29 | 2023-06-23 | 赛诺维信制药公司 | 化合物、组合物及其用途 |
| AU2017301767A1 (en) | 2016-07-29 | 2019-02-14 | Pgi Drug Discovery Llc | Compounds and compositions and uses thereof |
| CN110678205B (zh) | 2017-02-16 | 2023-05-23 | 桑诺维恩药品公司 | 治疗精神分裂症的方法 |
| EA201992638A1 (ru) | 2017-05-08 | 2020-03-18 | Арена Фармасьютикалз, Инк. | Соединения и способы для лечения висцеральной боли |
| KR20200036008A (ko) | 2017-08-02 | 2020-04-06 | 선오비온 파마슈티컬스 인코포레이티드 | 이소크로만 화합물 및 이의 용도 |
| JP7453148B2 (ja) | 2018-02-16 | 2024-03-19 | サノビオン ファーマシューティカルズ インク | 塩、結晶形態、およびその製造方法 |
| MX2021010880A (es) | 2019-03-14 | 2022-01-18 | Sunovion Pharmaceuticals Inc | Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas. |
| WO2021047583A1 (zh) * | 2019-09-12 | 2021-03-18 | 四川海思科制药有限公司 | 一种三环吡唑衍生物及其制备 |
| WO2021047581A1 (zh) * | 2019-09-12 | 2021-03-18 | 四川海思科制药有限公司 | 一种六氢化苯并吡唑衍生物及其制备 |
| MX2022012833A (es) | 2020-04-14 | 2022-11-07 | Sunovion Pharmaceuticals Inc | (s)-(4,5-dihidro-7h-tieno[2,3-c]piran-7-il)-n-metilmetanamina para tratar trastornos neurologicos y psiquiatricos. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2742148B1 (fr) * | 1995-12-08 | 1999-10-22 | Sanofi Sa | Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2800375B1 (fr) * | 1999-11-03 | 2004-07-23 | Sanofi Synthelabo | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant |
| JP2004502642A (ja) * | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
| EP1448557A4 (en) * | 2001-10-26 | 2005-02-02 | Univ Connecticut | HETEROINDANE: A NEW CLASS OF HIGH-ACTIVITY CANNABIMIMETIC LIGANDS |
| TW200602324A (en) * | 2004-03-24 | 2006-01-16 | Janssen Pharmaceutica Nv | Tetrahydro-indazole cannabinoid modulators cross reference to related applications |
-
2004
- 2004-09-13 FR FR0409712A patent/FR2875230A1/fr not_active Withdrawn
-
2005
- 2005-09-06 PE PE2005001028A patent/PE20060627A1/es not_active Application Discontinuation
- 2005-09-09 UY UY29112A patent/UY29112A1/es not_active Application Discontinuation
- 2005-09-09 AR ARP050103775A patent/AR051288A1/es not_active Application Discontinuation
- 2005-09-12 WO PCT/FR2005/002255 patent/WO2006030124A1/fr not_active Ceased
- 2005-09-12 TW TW094131307A patent/TW200621786A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006030124A1 (fr) | 2006-03-23 |
| UY29112A1 (es) | 2006-04-28 |
| TW200621786A (en) | 2006-07-01 |
| PE20060627A1 (es) | 2006-08-15 |
| FR2875230A1 (fr) | 2006-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR051288A1 (es) | Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica | |
| ATE302775T1 (de) | Carbolinderivate | |
| CR11596A (es) | Derivados de urea de tetrahidroquinoxalina, su preparacion y su aplicacion en terapeutica | |
| EA200702670A1 (ru) | Препарат тиенопиридинового ингибитора агрегации тромбоцитов | |
| DK1332137T3 (da) | Behandling af gastrointestinale stromale tumorer | |
| EA201001124A1 (ru) | Производные хинолина и их применение в качестве фунгицидов | |
| DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
| NO20044995L (no) | Heterosykliske forbindelser | |
| BR0116217A (pt) | Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas | |
| AR057705A1 (es) | 3-acilaminobenzanilidas insecticidas | |
| ATE377419T1 (de) | Substituierte 4-alkoxyoxazol derivate als ppar agonisten | |
| EA200970372A1 (ru) | Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение | |
| AR053774A1 (es) | Derivados de sulfonilbencimidazol. composiciones farmaceuticas. | |
| NO20075022L (no) | (7-(2-(4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyrid-1-yl)etyl) isokinolinbesylatsalt, fremstilling og terapeutiske anvendelser derav | |
| DOP2006000045A (es) | Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica | |
| SE0103710D0 (sv) | Compounds | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| EA200700997A1 (ru) | 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ | |
| AR057929A1 (es) | Compuestos de amidinfenilo y su uso como fungicidas | |
| EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| EA200800070A1 (ru) | Производные 2-(1h-индолилсульфанил)ариламина | |
| AR048589A1 (es) | Derivados de pirrolidina -3,4-dicarboxamida | |
| CR8340A (es) | Pirazolilcarboxanilidas n-sustituidas | |
| EA200300917A1 (ru) | Порошковый состав |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |